Strata Critical Medical Gross Margin 2020-2025 | SRTA
Current and historical gross margin for Strata Critical Medical (SRTA) over the last 10 years. The current gross profit margin for Strata Critical Medical as of September 30, 2025 is %.
| Strata Critical Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.27B | $0.07B | 25.09% |
| 2025-06-30 | $0.25B | $0.06B | 24.80% |
| 2025-03-31 | $0.25B | $0.06B | 24.30% |
| 2024-12-31 | $0.25B | $0.06B | 23.69% |
| 2024-09-30 | $0.20B | $0.04B | 21.18% |
| 2024-06-30 | $0.24B | $0.05B | 21.43% |
| 2024-03-31 | $0.23B | $0.05B | 19.48% |
| 2023-12-31 | $0.22B | $0.04B | 18.75% |
| 2023-09-30 | $0.22B | $0.04B | 17.67% |
| 2023-06-30 | $0.19B | $0.03B | 16.32% |
| 2023-03-31 | $0.17B | $0.03B | 15.76% |
| 2022-12-31 | $0.15B | $0.02B | 14.97% |
| 2022-09-30 | $0.14B | $0.02B | 16.20% |
| 2022-06-30 | $0.12B | $0.02B | 15.52% |
| 2022-03-31 | $0.09B | $0.02B | 17.20% |
| 2021-12-31 | $0.08B | $0.01B | 18.67% |
| 2021-03-31 | $0.01B | $0.00B | 16.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.408B | $0.249B |
| Strata Critical Medical provides time critical logistics solutions and specialized medical services to healthcare providers. Strata Critical Medical, formerly known as Blade Air Mobility Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Medpace Holdings (MEDP) | United States | $16.568B | 41.13 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |